{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T17:33:10Z","timestamp":1790530390319,"version":"4.1.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["INCa_16077"],"award-info":[{"award-number":["INCa_16077"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["RS18\/75-48,RS19\/75-63,RS20\/75-93,RS21 \/75-35"],"award-info":[{"award-number":["RS18\/75-48,RS19\/75-63,RS20\/75-93,RS21 \/75-35"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013874","name":"Association pour la Recherche sur les Tumeurs de la Prostate","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013874","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Interdisciplinary Thematic Institute IMCBio+","award":["ITI 2021-2028"],"award-info":[{"award-number":["ITI 2021-2028"]}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["Index Unistra ANR-10-IDEX-0002"],"award-info":[{"award-number":["Index Unistra ANR-10-IDEX-0002"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-20-SFRI-0012"],"award-info":[{"award-number":["ANR-20-SFRI-0012"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"French Ministry of Research","award":["PhD funding"],"award-info":[{"award-number":["PhD funding"]}]},{"name":"FONCER contre le cancer"},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["Annual funding"],"award-info":[{"award-number":["Annual funding"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","award":["Annual funding"],"award-info":[{"award-number":["Annual funding"]}],"id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e9 Paris Cit\u00e9","award":["Annual funding"],"award-info":[{"award-number":["Annual funding"]}]},{"name":"Alliance Nationale pour les Sciences de la Vie et de la Sant\u00e9 (Aviesan) and ITMO Cancer supported by Inserm","award":["PhD funding"],"award-info":[{"award-number":["PhD funding"]}]},{"name":"Ecole de l'Inserm Pfizer Innovation","award":["PhD funding"],"award-info":[{"award-number":["PhD funding"]}]},{"name":"Melanoma Research Alliance and the Wolfgang & Gertrud Boettcher Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A critical knowledge gap in prostate cancer research is understanding whether castration-tolerant progenitor-like cells that reside in treatment-na\u00efve tumors play a direct role in therapy resistance and tumor progression. Herein, we reveal that the castration tolerance of LSC\n                    <jats:sup>med<\/jats:sup>\n                    (Lin\n                    <jats:sup>-<\/jats:sup>\n                    , Sca-1\n                    <jats:sup>+<\/jats:sup>\n                    , CD49f\n                    <jats:sup>med<\/jats:sup>\n                    ) progenitor cells, the mouse equivalent of human prostatic Club cells, arises not from intrinsic properties, but from significant transcriptional reprogramming. Utilizing single-cell RNA sequencing of LSC\n                    <jats:sup>med<\/jats:sup>\n                    cells isolated from prostate-specific\n                    <jats:italic>Pten<\/jats:italic>\n                    -deficient (\n                    <jats:italic>Pten<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>pc\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    ) mice, we identify the emergence of castration-resistant LSC\n                    <jats:sup>med<\/jats:sup>\n                    cells enriched in stem-like features, driven by the transcription factor FOSL1\/AP-1. We demonstrate that cells exhibiting\n                    <jats:italic>Pten<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>pc\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    LSC\n                    <jats:sup>med<\/jats:sup>\n                    characteristics are prevalent in aggressive double-negative prostate cancer (DNPC) subtypes recently identified in human castration-resistant prostate cancer (CRPC). Furthermore, our findings show that the dual-targeting agents JQ-1 and CX-6258\u2014focused on FOSL1\/AP-1 and PIM kinases, respectively\u2014effectively suppress both the progenitor properties and the growth of mouse and human DNPC surrogates in vitro and in vivo. Thus, early eradication of castration-tolerant Club-like cells presents a promising therapeutic strategy to mitigate prostate cancer progression toward CRPC.\n                  <\/jats:p>","DOI":"10.1038\/s44321-026-00375-y","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T10:55:24Z","timestamp":1770029724000},"page":"943-978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Targeting pre-existing club-like cells in prostate cancer potentiates androgen deprivation therapy"],"prefix":"10.1038","volume":"18","author":[{"given":"Manon","family":"Baur\u00e8s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Vieira Aleixo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Pacreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5478-8544","authenticated-orcid":false,"given":"Aysis","family":"Koshy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4585-7971","authenticated-orcid":false,"given":"Vanessa","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0418-1107","authenticated-orcid":false,"given":"Marc","family":"Diedisheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Raigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1695-172X","authenticated-orcid":false,"given":"Yichao","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Dariane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Boutillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2184-1338","authenticated-orcid":false,"given":"Lukas","family":"Kenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Marine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2666-6877","authenticated-orcid":false,"given":"Gilles","family":"Laverny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5555-046X","authenticated-orcid":false,"given":"Daniel","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9727-8986","authenticated-orcid":false,"given":"Florian","family":"Rambow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9285-8167","authenticated-orcid":false,"given":"Jacques-Emmanuel","family":"Guidotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8021-3086","authenticated-orcid":false,"given":"Vincent","family":"Goffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"375_CR1","unstructured":"Abida W, Cyrta J, Heller G, Prandi D, Armenia J, Coleman I, Cieslik M, Benelli M, Robinson D, Van Allen EM et al (2019a) cBio Cancer Genomics Portal prad_su2c_2019 https:\/\/github.com\/cBioPortal\/datahub\/tree\/master\/public\/prad_su2c_2019"},{"key":"375_CR2","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.1073\/pnas.1902651116","volume":"116","author":"W Abida","year":"2019","unstructured":"Abida W, Cyrta J, Heller G, Prandi D, Armenia J, Coleman I, Cieslik M, Benelli M, Robinson D, Van Allen EM et al (2019b) Genomic correlates of clinical outcome in advanced prostate cancer. Proc Natl Acad Sci USA 116:11428\u201311436","journal-title":"Proc Natl Acad Sci USA"},{"key":"375_CR3","doi-asserted-by":"publisher","first-page":"eabo2295","DOI":"10.1126\/sciadv.abo2295","volume":"8","author":"MA Abu El Maaty","year":"2022","unstructured":"Abu El Maaty MA, Terzic J, Keime C, Rovito D, Lutzing R, Yanushko D, Parisotto M, Grelet E, Namer IJ, Lindner V et al (2022) Hypoxia-mediated stabilization of HIF1A in prostatic intraepithelial neoplasia promotes cell plasticity and malignant progression. Sci Adv 8:eabo2295","journal-title":"Sci Adv"},{"key":"375_CR4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, Gonzalez-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, Rambow F, Marine JC, Geurts P, Aerts J et al (2017) SCENIC: single-cell regulatory network inference and clustering. Nat Methods 14:1083\u20131086","journal-title":"Nat Methods"},{"key":"375_CR5","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1158\/0008-5472.CAN-12-0212","volume":"72","author":"D Albino","year":"2012","unstructured":"Albino D, Longoni N, Curti L, Mello-Grand M, Pinton S, Civenni G, Thalmann G, D\u2019Ambrosio G, Sarti M, Sessa F et al (2012) ESE3\/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like features. Cancer Res 72:2889\u20132900","journal-title":"Cancer Res"},{"key":"375_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/srep10120","volume":"5","author":"EK Baker","year":"2015","unstructured":"Baker EK, Taylor S, Gupte A, Sharp PP, Walia M, Walsh NC, Zannettino AC, Chalk AM, Burns CJ, Walkley CR (2015) BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells. Sci Rep 5:10120","journal-title":"Sci Rep"},{"key":"375_CR7","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1016\/j.celrep.2018.11.069","volume":"25","author":"JD Barros-Silva","year":"2018","unstructured":"Barros-Silva JD, Linn DE, Steiner I, Guo G, Ali A, Pakula H, Ashton G, Peset I, Brown M, Clarke NW et al (2018) Single-cell analysis identifies LY6D as a marker linking castration-resistant prostate luminal cells to prostate progenitors and cancer. Cell Rep 25:3504\u20133518.e3506","journal-title":"Cell Rep"},{"key":"375_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41585-021-00561-2","volume":"19","author":"M Baures","year":"2022","unstructured":"Baures M, Dariane C, Tika E, Puig Lombardi E, Barry Delongchamps N, Blanpain C, Guidotti JE, Goffin V (2022a) Prostate luminal progenitor cells: from mouse to human, from health to disease. Nat Rev Urol 19:201\u2013218","journal-title":"Nat Rev Urol"},{"key":"375_CR9","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.3390\/cancers14153775","volume":"14","author":"M Baures","year":"2022","unstructured":"Baures M, Puig Lombardi E, Di Martino D, Zeitouni W, Pacreau E, Dos Santos L, Dariane C, Boutillon F, Guidotti JE, Goffin V (2022b) Transcriptomic signature and growth factor regulation of castration-tolerant prostate luminal progenitor cells. Cancers 14:3775","journal-title":"Cancers"},{"key":"375_CR10","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s41587-020-0591-3","volume":"38","author":"V Bergen","year":"2020","unstructured":"Bergen V, Lange M, Peidli S, Wolf FA, Theis FJ (2020) Generalizing RNA velocity to transient cell states through dynamical modeling. Nat Biotechnol 38:1408\u20131414","journal-title":"Nat Biotechnol"},{"key":"375_CR11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41556-020-0514-z","volume":"22","author":"M Bi","year":"2020","unstructured":"Bi M, Zhang Z, Jiang YZ, Xue P, Wang H, Lai Z, Fu X, De Angelis C, Gong Y, Gao Z et al (2020) Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance. Nat Cell Biol 22:701\u2013715","journal-title":"Nat Cell Biol"},{"key":"375_CR12","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1158\/1535-7163.MCT-15-0567","volume":"15","author":"HK Bid","year":"2016","unstructured":"Bid HK, Phelps DA, Xaio L, Guttridge DC, Lin J, London C, Baker LH, Mo X, Houghton PJ (2016) The bromodomain BET inhibitor JQ1 suppresses tumor angiogenesis in models of childhood sarcoma. Mol Cancer Ther 15:1018\u20131028","journal-title":"Mol Cancer Ther"},{"key":"375_CR13","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ccell.2017.09.003","volume":"32","author":"EG Bluemn","year":"2017","unstructured":"Bluemn EG, Coleman IM, Lucas JM, Coleman RT, Hernandez-Lopez S, Tharakan R, Bianchi-Frias D, Dumpit RF, Kaipainen A, Corella AN et al (2017) Androgen receptor pathway-independent prostate cancer is sustained through FGF signaling. Cancer Cell 32:474\u2013489.e476","journal-title":"Cancer Cell"},{"key":"375_CR14","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"375_CR15","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1053\/hp.2000.6698","volume":"31","author":"L Bubendorf","year":"2000","unstructured":"Bubendorf L, Schopfer A, Wagner U, Sauter G, Moch H, Willi N, Gasser TC, Mihatsch MJ (2000) Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 31:578\u2013583","journal-title":"Hum Pathol"},{"key":"375_CR16","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.3390\/cancers14061480","volume":"14","author":"L Casalino","year":"2022","unstructured":"Casalino L, Talotta F, Cimmino A, Verde P (2022) The Fra-1\/AP-1 Oncoprotein: from the \u201cundruggable\u201d transcription factor to therapeutic targeting. Cancers 14:1480","journal-title":"Cancers"},{"key":"375_CR17","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1126\/science.abn0478","volume":"377","author":"JM Chan","year":"2022","unstructured":"Chan JM, Zaidi S, Love JR, Zhao JL, Setty M, Wadosky KM, Gopalan A, Choo ZN, Persad S, Choi J et al (2022) Lineage plasticity in prostate cancer depends on JAK\/STAT inflammatory signaling. Science 377:1180\u20131191","journal-title":"Science"},{"key":"375_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","volume":"23","author":"S Chen","year":"2021","unstructured":"Chen S, Zhu G, Yang Y, Wang F, Xiao YT, Zhang N, Bian X, Zhu Y, Yu Y, Liu F et al (2021) Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat Cell Biol 23:87\u201398","journal-title":"Nat Cell Biol"},{"key":"375_CR19","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.eururo.2021.12.039","volume":"81","author":"Q Cheng","year":"2022","unstructured":"Cheng Q, Butler W, Zhou Y, Zhang H, Tang L, Perkinson K, Chen X, Jiang XS, McCall SJ, Inman BA et al (2022) Pre-existing castration-resistant prostate cancer-like cells in primary prostate cancer promote resistance to hormonal therapy. Eur Urol 81:446\u2013455","journal-title":"Eur Urol"},{"key":"375_CR20","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.celrep.2019.07.007","volume":"28","author":"PD Crowell","year":"2019","unstructured":"Crowell PD, Fox JJ, Hashimoto T, Diaz JA, Navarro HI, Henry GH, Feldmar BA, Lowe MG, Garcia AJ, Wu YE et al (2019) Expansion of luminal progenitor cells in the aging mouse and human prostate. Cell Rep 28:1499\u20131510.e1496","journal-title":"Cell Rep"},{"key":"375_CR21","unstructured":"Crowley L, Cambuli F, Aparicio L, Shibata M, Robinson BD, Xuan S, Li W, Hibshoosh H, Loda M, Rabadan R et al (2020a) Gene expression omnibus GSE150692. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE150692"},{"key":"375_CR22","doi-asserted-by":"publisher","first-page":"e59465","DOI":"10.7554\/eLife.59465","volume":"9","author":"L Crowley","year":"2020","unstructured":"Crowley L, Cambuli F, Aparicio L, Shibata M, Robinson BD, Xuan S, Li W, Hibshoosh H, Loda M, Rabadan R et al (2020b) A single-cell atlas of the mouse and human prostate reveals heterogeneity and conservation of epithelial progenitors. Elife 9:e59465","journal-title":"Elife"},{"key":"375_CR23","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s42003-020-01476-1","volume":"3","author":"B Dong","year":"2020","unstructured":"Dong B, Miao J, Wang Y, Luo W, Ji Z, Lai H, Zhang M, Cheng X, Wang J, Fang Y et al (2020) Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer. Commun Biol 3:778","journal-title":"Commun Biol"},{"key":"375_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24137-1","volume":"12","author":"J Dong","year":"2021","unstructured":"Dong J, Li J, Li Y, Ma Z, Yu Y, Wang CY (2021) Transcriptional super-enhancers control cancer stemness and metastasis genes in squamous cell carcinoma. Nat Commun 12:3974","journal-title":"Nat Commun"},{"key":"375_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nprot.2016.006","volume":"11","author":"J Drost","year":"2016","unstructured":"Drost J, Karthaus WR, Gao D, Driehuis E, Sawyers CL, Chen Y, Clevers H (2016) Organoid culture systems for prostate epithelial and cancer tissue. Nat Protoc 11:347\u2013358","journal-title":"Nat Protoc"},{"key":"375_CR26","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nrc1209","volume":"3","author":"R Eferl","year":"2003","unstructured":"Eferl R, Wagner EF (2003) AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3:859\u2013868","journal-title":"Nat Rev Cancer"},{"key":"375_CR27","doi-asserted-by":"publisher","first-page":"eadv2367","DOI":"10.1126\/science.adv2367","volume":"389","author":"S Eyunni","year":"2025","unstructured":"Eyunni S, Mannan R, Zhang Y, Young E, Zhang Q, Luo J, Pang M, Mahapatra S, Tien JC, George JM et al (2025) Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticity. Science 389:eadv2367","journal-title":"Science"},{"key":"375_CR28","doi-asserted-by":"publisher","first-page":"e103209","DOI":"10.15252\/embj.2019103209","volume":"39","author":"N Feldker","year":"2020","unstructured":"Feldker N, Ferrazzi F, Schuhwerk H, Widholz SA, Guenther K, Frisch I, Jakob K, Kleemann J, Riegel D, Bonisch U et al (2020) Genome-wide cooperation of EMT transcription factor ZEB1 with YAP and AP-1 in breast cancer. EMBO J 39:e103209","journal-title":"EMBO J"},{"key":"375_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nature20788","volume":"541","author":"M Fraser","year":"2017","unstructured":"Fraser M, Sabelnykova VY, Yamaguchi TN, Heisler LE, Livingstone J, Huang V, Shiah YJ, Yousif F, Lin X, Masella AP et al (2017) Genomic hallmarks of localized, non-indolent prostate cancer. Nature 541:359\u2013364","journal-title":"Nature"},{"key":"375_CR30","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s12282-019-00966-3","volume":"26","author":"X Gao","year":"2019","unstructured":"Gao X, Liu X, Lu Y, Wang Y, Cao W, Liu X, Hu H, Wang H (2019) PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation. Breast Cancer 26:663\u2013671","journal-title":"Breast Cancer"},{"key":"375_CR31","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.ccell.2018.10.016","volume":"34","author":"C Gerhauser","year":"2018","unstructured":"Gerhauser C, Favero F, Risch T, Simon R, Feuerbach L, Assenov Y, Heckmann D, Sidiropoulos N, Waszak SM, Hubschmann D et al (2018) Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories. Cancer Cell 34:996\u20131011.e1018","journal-title":"Cancer Cell"},{"key":"375_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08133-6","volume":"10","author":"H Guo","year":"2019","unstructured":"Guo H, Ci X, Ahmed M, Hua JT, Soares F, Lin D, Puca L, Vosoughi A, Xue H, Li E et al (2019) ONECUT2 is a driver of neuroendocrine prostate cancer. Nat Commun 10:278","journal-title":"Nat Commun"},{"key":"375_CR33","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41588-020-0642-1","volume":"52","author":"W Guo","year":"2020","unstructured":"Guo W, Li L, He J, Liu Z, Han M, Li F, Xia X, Zhang X, Zhu Y, Wei Y et al (2020) Single-cell transcriptomics identifies a distinct luminal progenitor cell type in distal prostate invagination tips. Nat Genet 52:908\u2013918","journal-title":"Nat Genet"},{"key":"375_CR34","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1038\/onc.2012.412","volume":"32","author":"S Ha","year":"2013","unstructured":"Ha S, Iqbal NJ, Mita P, Ruoff R, Gerald WL, Lepor H, Taneja SS, Lee P, Melamed J, Garabedian MJ et al (2013) Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer. Oncogene 32:3992\u20134000","journal-title":"Oncogene"},{"key":"375_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1021\/ml200259q","volume":"3","author":"M Haddach","year":"2012","unstructured":"Haddach M, Michaux J, Schwaebe MK, Pierre F, O\u2019Brien SE, Borsan C, Tran J, Raffaele N, Ravula S, Drygin D et al (2012) Discovery of CX-6258. a potent, selective, and orally efficacious pan-Pim kinases inhibitor. ACS Med Chem Lett 3:135\u2013139","journal-title":"ACS Med Chem Lett"},{"key":"375_CR36","doi-asserted-by":"publisher","first-page":"110595","DOI":"10.1016\/j.celrep.2022.110595","volume":"39","author":"H Han","year":"2022","unstructured":"Han H, Wang Y, Curto J, Gurrapu S, Laudato S, Rumandla A, Chakraborty G, Wang X, Chen H, Jiang Y et al (2022) Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis. Cell Rep 39:110595","journal-title":"Cell Rep"},{"key":"375_CR37","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41591-021-01244-6","volume":"27","author":"MX He","year":"2021","unstructured":"He MX, Cuoco MS, Crowdis J, Bosma-Moody A, Zhang Z, Bi K, Kanodia A, Su MJ, Ku SY, Garcia MM et al (2021) Transcriptional mediators of treatment resistance in lethal prostate cancer. Nat Med 27:426\u2013433","journal-title":"Nat Med"},{"key":"375_CR38","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1016\/j.celrep.2018.11.086","volume":"25","author":"GH Henry","year":"2018","unstructured":"Henry GH, Malewska A, Joseph DB, Malladi VS, Lee J, Torrealba J, Mauck RJ, Gahan JC, Raj GV, Roehrborn CG et al (2018) A cellular anatomy of the normal adult human prostate and prostatic urethra. Cell Rep 25:3530\u20133542.e3535","journal-title":"Cell Rep"},{"key":"375_CR39","first-page":"362","volume":"119","author":"XF Hu","year":"2009","unstructured":"Hu XF, Li J, Vandervalk S, Wang Z, Magnuson NS, Xing PX (2009) PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis. J Clin Invest 119:362\u2013375","journal-title":"J Clin Invest"},{"key":"375_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giaf076","volume":"14","author":"Y Hua","year":"2025","unstructured":"Hua Y, Weng L, Zhao F, Rambow F (2025) SeuratExtend: streamlining single-cell RNA-seq analysis through an integrated and intuitive framework. Gigascience 14:giaf076","journal-title":"Gigascience"},{"key":"375_CR42","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1210\/en.2006-1250","volume":"148","author":"L Huang","year":"2007","unstructured":"Huang L, Pu Y, Hepps D, Danielpour D, Prins GS (2007) Posterior Hox gene expression and differential androgen regulation in the developing and adult rat prostate lobes. Endocrinology 148:1235\u20131245","journal-title":"Endocrinology"},{"key":"375_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0165-4608(00)00216-8","volume":"120","author":"B Hukku","year":"2000","unstructured":"Hukku B, Mally M, Cher ML, Peehl DM, Kung H, Rhim JS (2000) Stepwise genetic changes associated with progression of nontumorigenic HPV-18 immortalized human prostate cancer-derived cell line to a malignant phenotype. Cancer Genet Cytogenet 120:117\u2013126","journal-title":"Cancer Genet Cytogenet"},{"key":"375_CR44","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/sj.bjc.6604242","volume":"98","author":"EM Hurt","year":"2008","unstructured":"Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL (2008) CD44+ CD24(-) prostate cells are early cancer progenitor\/stem cells that provide a model for patients with poor prognosis. Br J Cancer 98:756\u2013765","journal-title":"Br J Cancer"},{"key":"375_CR45","doi-asserted-by":"publisher","first-page":"43146","DOI":"10.18632\/oncotarget.6454","volume":"6","author":"S Iskit","year":"2015","unstructured":"Iskit S, Schlicker A, Wessels L, Peeper DS (2015) Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival. Oncotarget 6:43146\u201343161","journal-title":"Oncotarget"},{"key":"375_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/srep38079","volume":"6","author":"MP Jimenez-Garcia","year":"2016","unstructured":"Jimenez-Garcia MP, Lucena-Cacace A, Robles-Frias MJ, Narlik-Grassow M, Blanco-Aparicio C, Carnero A (2016) The role of PIM1\/PIM2 kinases in tumors of the male reproductive system. Sci Rep 6:38079","journal-title":"Sci Rep"},{"key":"375_CR47","unstructured":"Joseph DB, Henry GH, Malewska A, Iqbal NS, Ruetten HM, Turco AE, Abler LL, Sandhu SK, Cadena MT, Malladi VS et al (2020a) Gene expression omnibus GSE145861. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE145861"},{"key":"375_CR48","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/pros.24020","volume":"80","author":"DB Joseph","year":"2020","unstructured":"Joseph DB, Henry GH, Malewska A, Iqbal NS, Ruetten HM, Turco AE, Abler LL, Sandhu SK, Cadena MT, Malladi VS et al (2020b) Urethral luminal epithelia are castration-insensitive cells of the proximal prostate. Prostate 80:872\u2013884","journal-title":"Prostate"},{"key":"375_CR49","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.3390\/ijms25052836","volume":"25","author":"AR Jung","year":"2024","unstructured":"Jung AR, Shin S, Kim MY, Ha US, Hong SH, Lee JY, Kim SW, Chung YJ, Park YH (2024) Integrated bioinformatics analysis identified ASNS and DDIT3 as the therapeutic target in castrate-resistant prostate cancer. Int J Mol Sci 25:2836","journal-title":"Int J Mol Sci"},{"key":"375_CR50","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.devcel.2022.01.006","volume":"57","author":"P Kadur Lakshminarasimha Murthy","year":"2022","unstructured":"Kadur Lakshminarasimha Murthy P, Xi R, Arguijo D, Everitt JI, Kocak DD, Kobayashi Y, Bozec A, Vicent S, Ding S, Crawford GE et al (2022) Epigenetic basis of oncogenic-Kras-mediated epithelial-cellular proliferation and plasticity. Dev Cell 57:310\u2013328.e319","journal-title":"Dev Cell"},{"key":"375_CR51","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/cas.12914","volume":"107","author":"D Kamide","year":"2016","unstructured":"Kamide D, Yamashita T, Araki K, Tomifuji M, Tanaka Y, Tanaka S, Shiozawa S, Shiotani A (2016) Selective activator protein-1 inhibitor T-5224 prevents lymph node metastasis in an oral cancer model. Cancer Sci 107:666\u2013673","journal-title":"Cancer Sci"},{"key":"375_CR52","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1126\/science.aay0267","volume":"368","author":"WR Karthaus","year":"2020","unstructured":"Karthaus WR, Hofree M, Choi D, Linton EL, Turkekul M, Bejnood A, Carver B, Gopalan A, Abida W, Laudone V et al (2020) Regenerative potential of prostate luminal cells revealed by single-cell analysis. Science 368:497\u2013505","journal-title":"Science"},{"key":"375_CR53","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.stem.2024.05.008","volume":"31","author":"JS Kirk","year":"2024","unstructured":"Kirk JS, Wang J, Long M, Rosario S, Tracz A, Ji Y, Kumar R, Liu X, Jamroze A, Singh PK et al (2024) Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells. Cell Stem Cell 31:1203\u20131221.e1207","journal-title":"Cell Stem Cell"},{"key":"375_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54364-1","volume":"15","author":"A Kiviaho","year":"2024","unstructured":"Kiviaho A, Eerola SK, Kallio HML, Andersen MK, Hoikka M, Tiihonen AM, Salonen I, Spotbeen X, Giesen A, Parker CTA et al (2024) Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer. Nat Commun 15:9949","journal-title":"Nat Commun"},{"key":"375_CR55","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41388-020-01526-2","volume":"40","author":"OJ Kwon","year":"2021","unstructured":"Kwon OJ, Zhang L, Jia D, Xin L (2021) Sox2 is necessary for androgen ablation-induced neuroendocrine differentiation from Pten null Sca-1(+) prostate luminal cells. Oncogene 40:203\u2013214","journal-title":"Oncogene"},{"key":"375_CR56","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-018-0414-6","volume":"560","author":"G La Manno","year":"2018","unstructured":"La Manno G, Soldatov R, Zeisel A, Braun E, Hochgerner H, Petukhov V, Lidschreiber K, Kastriti ME, Lonnerberg P, Furlan A et al (2018) RNA velocity of single cells. Nature 560:494\u2013498","journal-title":"Nature"},{"key":"375_CR57","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1172\/JCI128212","volume":"129","author":"MP Labrecque","year":"2019","unstructured":"Labrecque MP, Coleman IM, Brown LG, True LD, Kollath L, Lakely B, Nguyen HM, Yang YC, da Costa RMG, Kaipainen A et al (2019) Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer. J Clin Invest 129:4492\u20134505","journal-title":"J Clin Invest"},{"key":"375_CR58","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1002\/cam4.2385","volume":"8","author":"F Li","year":"2019","unstructured":"Li F, Yang C, Zhang HB, Ma J, Jia J, Tang X, Zeng J, Chong T, Wang X, He D et al (2019) BET inhibitor JQ1 suppresses cell proliferation via inducing autophagy and activating LKB1\/AMPK in bladder cancer cells. Cancer Med 8:4792\u20134805","journal-title":"Cancer Med"},{"key":"375_CR59","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1158\/2159-8290.CD-21-0576","volume":"12","author":"S Linder","year":"2022","unstructured":"Linder S, Hoogstraat M, Stelloo S, Eickhoff N, Schuurman K, de Barros H, Alkemade M, Bekers EM, Severson TM, Sanders J et al (2022a) Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer toward androgen independence. Cancer Discov 12:2074\u20132097","journal-title":"Cancer Discov"},{"key":"375_CR60","unstructured":"Linder S, Hoogstraat M, Stelloo S, Eickhoff N, Schuurman K, de Barros H, Alkemade M, Bekers EM, Severson TM, Sanders J et al (2022b) European genome-phenome archive (EGA) https:\/\/ega-archive.org\/studies\/EGAS00001006016"},{"key":"375_CR61","doi-asserted-by":"publisher","first-page":"19408","DOI":"10.1073\/pnas.1216363109","volume":"109","author":"WW Lockwood","year":"2012","unstructured":"Lockwood WW, Zejnullahu K, Bradner JE, Varmus H (2012) Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins. Proc Natl Acad Sci USA 109:19408\u201319413","journal-title":"Proc Natl Acad Sci USA"},{"key":"375_CR62","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nprot.2010.11","volume":"5","author":"RU Lukacs","year":"2010","unstructured":"Lukacs RU, Goldstein AS, Lawson DA, Cheng D, Witte ON (2010) Isolation, cultivation and characterization of adult murine prostate stem cells. Nat Protoc 5:702\u2013713","journal-title":"Nat Protoc"},{"key":"375_CR63","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1158\/0008-5472.CAN-23-0593","volume":"83","author":"A Lundberg","year":"2023","unstructured":"Lundberg A, Zhang M, Aggarwal R, Li H, Zhang L, Foye A, Sjostrom M, Chou J, Chang K, Moreno-Rodriguez T et al (2023) The genomic and epigenomic landscape of double-negative metastatic prostate cancer. Cancer Res 83:2763\u20132774","journal-title":"Cancer Res"},{"key":"375_CR64","doi-asserted-by":"crossref","unstructured":"Marques C, Unterkircher T, Kroon P, Oldrini B, Izzo A, Dramaretska Y, Ferrarese R, Kling E, Schnell O, Nelander S et al (2021) NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1. Elife 10:e64846","DOI":"10.7554\/eLife.64846"},{"key":"375_CR65","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41588-022-01047-6","volume":"54","author":"J Marsolier","year":"2022","unstructured":"Marsolier J, Prompsy P, Durand A, Lyne AM, Landragin C, Trouchet A, Bento ST, Eisele A, Foulon S, Baudre L et al (2022) H3K27me3 conditions chemotolerance in triple-negative breast cancer. Nat Genet 54:459\u2013468","journal-title":"Nat Genet"},{"key":"375_CR66","doi-asserted-by":"publisher","first-page":"e60225","DOI":"10.7554\/eLife.60225","volume":"9","author":"R Mevel","year":"2020","unstructured":"Mevel R, Steiner I, Mason S, Galbraith LC, Patel R, Fadlullah MZ, Ahmad I, Leung HY, Oliveira P, Blyth K et al (2020) RUNX1 marks a luminal castration-resistant lineage established at the onset of prostate development. Elife 9:e60225","journal-title":"Elife"},{"key":"375_CR67","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.devcel.2018.12.023","volume":"48","author":"N Meyer-Schaller","year":"2019","unstructured":"Meyer-Schaller N, Cardner M, Diepenbruck M, Saxena M, Tiede S, Luond F, Ivanek R, Beerenwinkel N, Christofori G (2019) A Hierarchical regulatory landscape during the multiple stages of EMT. Dev Cell 48:539\u2013553.e536","journal-title":"Dev Cell"},{"key":"375_CR68","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/ng950","volume":"32","author":"H Mikkers","year":"2002","unstructured":"Mikkers H, Allen J, Knipscheer P, Romeijn L, Hart A, Vink E, Berns A (2002) High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat Genet 32:153\u2013159","journal-title":"Nat Genet"},{"key":"375_CR69","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.ccr.2011.05.006","volume":"19","author":"DJ Mulholland","year":"2011","unstructured":"Mulholland DJ, Tran LM, Li Y, Cai H, Morim A, Wang S, Plaisier S, Garraway IP, Huang J, Graeber TG et al (2011) Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth. Cancer Cell 19:792\u2013804","journal-title":"Cancer Cell"},{"key":"375_CR70","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/labinvest.3700112","volume":"84","author":"AL Omara-Opyene","year":"2004","unstructured":"Omara-Opyene AL, Qiu J, Shah GV, Iczkowski KA (2004) Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18. Lab Invest 84:894\u2013907","journal-title":"Lab Invest"},{"key":"375_CR71","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nprot.2014.006","volume":"9","author":"S Picelli","year":"2014","unstructured":"Picelli S, Faridani OR, Bjorklund AK, Winberg G, Sagasser S, Sandberg R (2014) Full-length RNA-seq from single cells using Smart-seq2. Nat Protoc 9:171\u2013181","journal-title":"Nat Protoc"},{"key":"375_CR72","doi-asserted-by":"publisher","first-page":"W72","DOI":"10.1093\/nar\/gkv529","volume":"43","author":"JP Pinto","year":"2015","unstructured":"Pinto JP, Kalathur RK, Oliveira DV, Barata T, Machado RS, Machado S, Pacheco-Leyva I, Duarte I, Futschik ME (2015) StemChecker: a web-based tool to discover and explore stemness signatures in gene sets. Nucleic Acids Res 43:W72\u2013W77","journal-title":"Nucleic Acids Res"},{"key":"375_CR73","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2415308122","volume":"122","author":"SP Pitzen","year":"2025","unstructured":"Pitzen SP, Rudenick AN, Qiu Y, Zhang W, Munro SA, McCluskey BM, Forster C, Bergom HE, Ali A, Boytim E et al (2025) Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial cell identity in castration-resistant prostate cancer. Proc Natl Acad Sci USA 122:e2415308122","journal-title":"Proc Natl Acad Sci USA"},{"key":"375_CR74","first-page":"397","volume":"10","author":"C Qian","year":"2022","unstructured":"Qian C, Yang Q, Freedland SJ, Di Vizio D, Ellis L, You S, Freeman MR (2022) Activation of ONECUT2 by RB1 loss in castration-resistant prostate cancer. Am J Clin Exp Urol 10:397\u2013407","journal-title":"Am J Clin Exp Urol"},{"key":"375_CR75","doi-asserted-by":"publisher","first-page":"7740","DOI":"10.1093\/nar\/gkae547","volume":"52","author":"C Qian","year":"2024","unstructured":"Qian C, Yang Q, Rotinen M, Huang R, Kim H, Gallent B, Yan Y, Cadaneanu RM, Zhang B, Kaochar S et al (2024) ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer. Nucleic Acids Res 52:7740\u20137760","journal-title":"Nucleic Acids Res"},{"key":"375_CR76","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nature11674","volume":"493","author":"J Qin","year":"2013","unstructured":"Qin J, Wu SP, Creighton CJ, Dai F, Xie X, Cheng CM, Frolov A, Ayala G, Lin X, Feng XH et al (2013) COUP-TFII inhibits TGF-beta-induced growth barrier to promote prostate tumorigenesis. Nature 493:236\u2013240","journal-title":"Nature"},{"key":"375_CR77","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1158\/1078-0432.CCR-16-0124","volume":"22","author":"RJ Rebello","year":"2016","unstructured":"Rebello RJ, Kusnadi E, Cameron DP, Pearson HB, Lesmana A, Devlin JR, Drygin D, Clark AK, Porter L, Pedersen J et al (2016) The dual inhibition of RNA Pol I transcription and PIM kinase as a new therapeutic approach to treat advanced prostate cancer. Clin Cancer Res 22:5539\u20135552","journal-title":"Clin Cancer Res"},{"key":"375_CR78","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1038\/s41591-018-0241-1","volume":"24","author":"M Rotinen","year":"2018","unstructured":"Rotinen M, You S, Yang J, Coetzee SG, Reis-Sobreiro M, Huang WC, Huang F, Pan X, Yanez A, Hazelett DJ et al (2018) ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis. Nat Med 24:1887\u20131898","journal-title":"Nat Med"},{"key":"375_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.132030","volume":"270","author":"AK Rout","year":"2024","unstructured":"Rout AK, Dehury B, Parida SN, Rout SS, Jena R, Kaushik N, Kaushik NK, Pradhan SK, Sahoo CR, Singh AK et al (2024) A review on structure-function mechanism and signaling pathway of serine\/threonine protein PIM kinases as a therapeutic target. Int J Biol Macromol 270:132030","journal-title":"Int J Biol Macromol"},{"key":"375_CR80","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/path.4924","volume":"243","author":"L Sackmann Sala","year":"2017","unstructured":"Sackmann Sala L, Boutillon F, Menara G, De Goyon-Pelard A, Leprevost M, Codzamanian J, Lister N, Pencik J, Clark A, Cagnard N et al (2017) A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumors. J Pathol 243:54\u201364","journal-title":"J Pathol"},{"key":"375_CR81","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1016\/j.ajpath.2014.07.020","volume":"184","author":"L Sackmann-Sala","year":"2014","unstructured":"Sackmann-Sala L, Chiche A, Mosquera-Garrote N, Boutillon F, Cordier C, Pourmir I, Pascual-Mathey L, Kessal K, Pigat N, Camparo P et al (2014) Prolactin-induced prostate tumorigenesis links sustained Stat5 signaling with the amplification of basal\/stem cells and emergence of putative luminal progenitors. Am J Pathol 184:3105\u20133119","journal-title":"Am J Pathol"},{"key":"375_CR82","doi-asserted-by":"publisher","first-page":"e0130340","DOI":"10.1371\/journal.pone.0130340","volume":"10","author":"NM Santio","year":"2015","unstructured":"Santio NM, Eerola SK, Paatero I, Yli-Kauhaluoma J, Anizon F, Moreau P, Tuomela J, Harkonen P, Koskinen PJ (2015) Pim kinases promote migration and metastatic growth of postate cancer xenografts. PLoS ONE 10:e0130340","journal-title":"PLoS ONE"},{"key":"375_CR83","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1158\/1078-0432.CCR-12-3904","volume":"19","author":"T Shimamura","year":"2013","unstructured":"Shimamura T, Chen Z, Soucheray M, Carretero J, Kikuchi E, Tchaicha JH, Gao Y, Cheng KA, Cohoon TJ, Qi J et al (2013) Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer. Clin Cancer Res 19:6183\u20136192","journal-title":"Clin Cancer Res"},{"key":"375_CR84","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature16508","volume":"529","author":"S Shu","year":"2016","unstructured":"Shu S, Lin CY, He HH, Witwicki RM, Tabassum DP, Roberts JM, Janiszewska M, Huh SJ, Liang Y, Ryan J et al (2016) Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer. Nature 529:413\u2013417","journal-title":"Nature"},{"key":"375_CR85","doi-asserted-by":"publisher","first-page":"E6544","DOI":"10.1073\/pnas.1518007112","volume":"112","author":"BA Smith","year":"2015","unstructured":"Smith BA, Sokolov A, Uzunangelov V, Baertsch R, Newton Y, Graim K, Mathis C, Cheng D, Stuart JM, Witte ON (2015) A basal stem cell signature identifies aggressive prostate cancer phenotypes. Proc Natl Acad Sci USA 112:E6544\u2013E6552","journal-title":"Proc Natl Acad Sci USA"},{"key":"375_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27322-4","volume":"13","author":"H Song","year":"2022","unstructured":"Song H, Weinstein HNW, Allegakoen P, Wadsworth 2ndMH, Xie J, Yang H, Castro EA, Lu KL, Stohr BA, Feng FY et al (2022) Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states. Nat Commun 13:141","journal-title":"Nat Commun"},{"key":"375_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112377","volume":"42","author":"I Steiner","year":"2023","unstructured":"Steiner I, Flores-Tellez T, Mevel R, Ali A, Wang P, Schofield P, Behan C, Forsythe N, Ashton G, Taylor C et al (2023) Autocrine activation of MAPK signaling mediates intrinsic tolerance to androgen deprivation in LY6D prostate cancer cells. Cell Rep 42:112377","journal-title":"Cell Rep"},{"key":"375_CR88","doi-asserted-by":"publisher","first-page":"eabe1505","DOI":"10.1126\/science.abe1505","volume":"376","author":"F Tang","year":"2022","unstructured":"Tang F, Xu D, Wang S, Wong CK, Martinez-Fundichely A, Lee CJ, Cohen S, Park J, Hill CE, Eng K et al (2022) Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets. Science 376:eabe1505","journal-title":"Science"},{"key":"375_CR89","doi-asserted-by":"publisher","first-page":"187ra171","DOI":"10.1126\/scitranslmed.3005688","volume":"5","author":"R Toivanen","year":"2013","unstructured":"Toivanen R, Frydenberg M, Murphy D, Pedersen J, Ryan A, Pook D, Berman DM, Taylor RA, Risbridger GP (2013) A preclinical xenograft model identifies castration-tolerant cancer-repopulating cells in localized prostate tumors. Sci Transl Med 5:187ra171","journal-title":"Sci Transl Med"},{"key":"375_CR90","first-page":"113","volume":"1","author":"CP Tran","year":"2002","unstructured":"Tran CP, Lin C, Yamashiro J, Reiter RE (2002) Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells. Mol Cancer Res 1:113\u2013121","journal-title":"Mol Cancer Res"},{"key":"375_CR91","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1002\/j.1460-2075.1995.tb07251.x","volume":"14","author":"NM van der Lugt","year":"1995","unstructured":"van der Lugt NM, Domen J, Verhoeven E, Linders K, van der Gulden H, Allen J, Berns A (1995) Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2. EMBO J 14:2536\u20132544","journal-title":"EMBO J"},{"key":"375_CR92","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1001\/jamaoncol.2020.6973","volume":"7","author":"L Wang","year":"2021","unstructured":"Wang L, Paller CJ, Hong H, De Felice A, Alexander GC, Brawley O (2021) Comparison of systemic treatments for metastatic castration-sensitive prostate cancer: a systematic review and network meta-analysis. JAMA Oncol 7:412\u2013420","journal-title":"JAMA Oncol"},{"key":"375_CR93","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1535-6108(03)00215-0","volume":"4","author":"S Wang","year":"2003","unstructured":"Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J, Thomas GV, Li G, Roy-Burman P, Nelson PS et al (2003) Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4:209\u2013221","journal-title":"Cancer Cell"},{"key":"375_CR94","unstructured":"Wang XD, Reeves K, Luo FR, Xu LA, Lee F, Clark E, Huang F (2007a) Gene expression omnibus GSE9633. https:\/\/www.ncbi.nlm.nih.gov\/geo\/geo2r\/?acc=GSE9633"},{"key":"375_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2007-8-11-r255","volume":"8","author":"XD Wang","year":"2007","unstructured":"Wang XD, Reeves K, Luo FR, Xu LA, Lee F, Clark E, Huang F (2007b) Identification of candidate predictive and surrogate molecular markers for dasatinib in prostate cancer: rationale for patient selection and efficacy monitoring. Genome Biol 8:R255","journal-title":"Genome Biol"},{"key":"375_CR96","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4142\/jvs.2001.2.3.167","volume":"2","author":"Z Wang","year":"2001","unstructured":"Wang Z, Bhattacharya N, Weaver M, Petersen K, Meyer M, Gapter L, Magnuson NS (2001) Pim-1: a serine\/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. J Vet Sci 2:167\u2013179","journal-title":"J Vet Sci"},{"key":"375_CR97","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/s41388-019-1080-3","volume":"39","author":"Z Wang","year":"2020","unstructured":"Wang Z, Li Y, Wu D, Yu S, Wang Y, Leung Chan F (2020) Nuclear receptor HNF4alpha performs a tumor suppressor function in prostate cancer via its induction of p21-driven cellular senescence. Oncogene 39:1572\u20131589","journal-title":"Oncogene"},{"key":"375_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49234-9","volume":"15","author":"Z Wang","year":"2024","unstructured":"Wang Z, Townley SL, Zhang S, Liu M, Li M, Labaf M, Patalano S, Venkataramani K, Siegfried KR, Macoska JA et al (2024) FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer. Nat Commun 15:4914","journal-title":"Nat Commun"},{"key":"375_CR99","first-page":"5579","volume":"54","author":"PC Weijerman","year":"1994","unstructured":"Weijerman PC, Konig JJ, Wong ST, Niesters HG, Peehl DM (1994) Lipofection-mediated immortalization of human prostatic epithelial cells of normal and malignant origin using human papillomavirus type 18 DNA. Cancer Res 54:5579\u20135583","journal-title":"Cancer Res"},{"key":"375_CR100","doi-asserted-by":"publisher","first-page":"47891","DOI":"10.18632\/oncotarget.10294","volume":"7","author":"L Xiao","year":"2016","unstructured":"Xiao L, Feng Q, Zhang Z, Wang F, Lydon JP, Ittmann MM, Xin L, Mitsiades N, He B (2016) The essential role of GATA transcription factors in adult murine prostate. Oncotarget 7:47891\u201347903","journal-title":"Oncotarget"},{"key":"375_CR101","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-020-01003-9","volume":"23","author":"Y Yamada","year":"2021","unstructured":"Yamada Y, Beltran H (2021) Clinical and biological features of neuroendocrine prostate cancer. Curr Oncol Rep 23:15","journal-title":"Curr Oncol Rep"},{"key":"375_CR102","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1084","volume":"12","author":"Q Yan","year":"2022","unstructured":"Yan Q, Wang M, Xia H, Dai C, Diao T, Wang Y, Hou H, Zhang H, Liu M, Long X (2022) Single-cell RNA-sequencing technology demonstrates the heterogeneity between aged prostate peripheral and transitional zone. Clin Transl Med 12:e1084","journal-title":"Clin Transl Med"},{"key":"375_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107613","volume":"151","author":"SU Zaman","year":"2024","unstructured":"Zaman SU, Pagare PP, Huang B, Rilee G, Ma Z, Zhang Y, Li J (2024) Novel PROTAC probes targeting FOSL1 degradation to eliminate head and neck squamous cell carcinoma cancer stem cells. Bioorg Chem 151:107613","journal-title":"Bioorg Chem"},{"key":"375_CR104","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/ncb3216","volume":"17","author":"F Zanconato","year":"2015","unstructured":"Zanconato F, Forcato M, Battilana G, Azzolin L, Quaranta E, Bodega B, Rosato A, Bicciato S, Cordenonsi M, Piccolo S (2015) Genome-wide association between YAP\/TAZ\/TEAD and AP-1 at enhancers drives oncogenic growth. Nat Cell Biol 17:1218\u20131227","journal-title":"Nat Cell Biol"},{"key":"375_CR105","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.923411","volume":"26","author":"MY Zhang","year":"2020","unstructured":"Zhang MY, Liu SL, Huang WL, Tang DB, Zheng WW, Zhou N, Zhou H, Abudureheman T, Tang ZH, Zhou BS et al (2020) Bromodomains and extra-terminal (BET) inhibitor JQ1 suppresses proliferation of acute lymphocytic leukemia by inhibiting c-Myc-mediated glycolysis. Med Sci Monit 26:e923411","journal-title":"Med Sci Monit"},{"key":"375_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108304","volume":"202","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Duan S, Jang A, Mao L, Liu X, Huang G (2021) JQ1, a selective inhibitor of BRD4, suppresses retinoblastoma cell growth by inducing cell cycle arrest and apoptosis. Exp Eye Res 202: 08304","journal-title":"Exp Eye Res"},{"key":"375_CR107","doi-asserted-by":"publisher","first-page":"6570","DOI":"10.7150\/jca.100604","volume":"15","author":"K Zhou","year":"2024","unstructured":"Zhou K, Lu H, Zhang J, Shen Q, Liu P, Xu Q, Yang C, Mao L (2024) Prostate cancer stem cells: an updated mini-review. J Cancer 15:6570\u20136576","journal-title":"J Cancer"},{"key":"375_CR108","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.cell.2009.07.031","volume":"138","author":"A Zippo","year":"2009","unstructured":"Zippo A, Serafini R, Rocchigiani M, Pennacchini S, Krepelova A, Oliviero S (2009) Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell 138:1122\u20131136","journal-title":"Cell"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00375-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00375-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00375-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:44:26Z","timestamp":1779065066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00375-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":107,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,13]]}},"alternative-id":["375"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00375-y","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}